{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:11:49Z","timestamp":1785773509058,"version":"3.56.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T00:00:00Z","timestamp":1459382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s12020-016-0931-8","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T16:47:04Z","timestamp":1459442824000},"page":"256-265","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism"],"prefix":"10.1007","volume":"55","author":[{"given":"Giuseppe","family":"Viccica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena","family":"Cetani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edda","family":"Vignali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Miccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Marcocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,31]]},"reference":[{"issue":"1","key":"931_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jocd.2012.11.005","volume":"16","author":"SJ Silverberg","year":"2013","unstructured":"S.J. Silverberg, M.D. Walker, J.P. Bilezikian, Asymptomatic primary hyperparathyroidism. J. Clin. Densitom. 16(1), 14\u201321 (2013). doi: 10.1016\/j.jocd.2012.11.005","journal-title":"J. Clin. Densitom."},{"key":"931_CR2","doi-asserted-by":"publisher","first-page":"164939","DOI":"10.1155\/2013\/164939","volume":"2013","author":"E Nordenstrom","year":"2013","unstructured":"E. Nordenstrom, A. Sitges-Serra, J.J. Sancho, M. Thier, M. Almquist, Vitamin d status in patients operated for primary hyperparathyroidism: comparison of patients from Southern and Northern Europe. Int. J. Endocrinol. 2013, 164939 (2013). doi: 10.1155\/2013\/164939","journal-title":"Int. J. Endocrinol."},{"key":"931_CR3","doi-asserted-by":"publisher","first-page":"921814","DOI":"10.1155\/2011\/921814","volume":"2011","author":"PV Pradeep","year":"2011","unstructured":"P.V. Pradeep, B. Jayashree, A. Mishra, S.K. Mishra, Systematic review of primary hyperparathyroidism in India: the past, present, and the future trends. Int. J. Endocrinol. 2011, 921814 (2011). doi: 10.1155\/2011\/921814","journal-title":"Int. J. Endocrinol."},{"issue":"2","key":"931_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4248\/BR201302005","volume":"1","author":"JM Liu","year":"2013","unstructured":"J.M. Liu, N.E. Cusano, B.C. Silva, L. Zhao, X.Y. He, B. Tao, L.H. Sun, H.Y. Zhao, W.W. Fan, M.E. Romano, G. Ning, J.P. Bilezikian, Primary hyperparathyroidism: a tale of two cities revisited\u2014New York and Shanghai. Bone. Res. 1(2), 162\u2013169 (2013). doi: 10.4248\/BR201302005","journal-title":"Bone. Res."},{"issue":"1","key":"931_CR5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1530\/EJE-13-0085","volume":"169","author":"S Varshney","year":"2013","unstructured":"S. Varshney, S.K. Bhadada, U.N. Saikia, N. Sachdeva, A. Behera, A.K. Arya, S. Sharma, A. Bhansali, A. Mithal, S.D. Rao, Simultaneous expression analysis of vitamin D receptor, calcium-sensing receptor, cyclin D1, and PTH in symptomatic primary hyperparathyroidism in Asian Indians. Eur. J. Endocrinol. 169(1), 109\u2013116 (2013). doi: 10.1530\/EJE-13-0085","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"931_CR6","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.jada.2011.01.004","volume":"111","author":"AC Ross","year":"2011","unstructured":"A.C. Ross, J.E. Manson, S.A. Abrams, J.F. Aloia, P.M. Brannon, S.K. Clinton, R.A. Durazo-Arvizu, J.C. Gallagher, R.L. Gallo, G. Jones, C.S. Kovacs, S.T. Mayne, C.J. Rosen, S.A. Shapses, The 2011 dietary reference intakes for calcium and vitamin D: what dietetics practitioners need to know. J. Am. Diet. Assoc. 111(4), 524\u2013527 (2011). doi: 10.1016\/j.jada.2011.01.004","journal-title":"J. Am. Diet. Assoc."},{"issue":"10","key":"931_CR7","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1210\/jc.2014-1417","volume":"99","author":"C Marcocci","year":"2014","unstructured":"C. Marcocci, J. Bollerslev, A.A. Khan, D.M. Shoback, Medical management of primary hyperparathyroidism: proceedings of the fourth international workshop on the management of asymptomatic primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 99(10), 3607\u20133618 (2014). doi: 10.1210\/jc.2014-1417","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"931_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jss.2007.06.009","volume":"143","author":"TD Beyer","year":"2007","unstructured":"T.D. Beyer, E.L. Chen, N. Nilubol, R.A. Prinz, C.C. Solorzano, Short-term outcomes of parathyroidectomy in patients with or without 25-hydroxy vitamin D insufficiency. J. Surg. Res. 143(1), 145\u2013150 (2007). doi: 10.1016\/j.jss.2007.06.009","journal-title":"J. Surg. Res."},{"issue":"3","key":"931_CR9","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1210\/jcem.85.3.6440","volume":"85","author":"DS Rao","year":"2000","unstructured":"D.S. Rao, M. Honasoge, G.W. Divine, E.R. Phillips, M.W. Lee, M.R. Ansari, G.B. Talpos, A.M. Parfitt, Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. J. Clin. Endocrinol. Metab. 85(3), 1054\u20131058 (2000). doi: 10.1210\/jcem.85.3.6440","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"931_CR10","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1365-2265.2005.02371.x","volume":"63","author":"B Moosgaard","year":"2005","unstructured":"B. Moosgaard, P. Vestergaard, L. Heickendorff, F. Melsen, P. Christiansen, L. Mosekilde, Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin. Endocrinol. 63(5), 506\u2013513 (2005). doi: 10.1111\/j.1365-2265.2005.02371.x","journal-title":"Clin. Endocrinol."},{"issue":"6","key":"931_CR11","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/BF03344140","volume":"29","author":"P Boudou","year":"2006","unstructured":"P. Boudou, F. Ibrahim, C. Cormier, E. Sarfati, J.C. Souberbielle, A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism. J. Endocrinol. Invest. 29(6), 511\u2013515 (2006). doi: 10.1007\/BF03344140","journal-title":"J. Endocrinol. Invest."},{"issue":"6","key":"931_CR12","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0002-9343(99)00294-6","volume":"107","author":"SJ Silverberg","year":"1999","unstructured":"S.J. Silverberg, E. Shane, D.W. Dempster, J.P. Bilezikian, The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. Am. J. Med. 107(6), 561\u2013567 (1999)","journal-title":"Am. J. Med."},{"issue":"1","key":"931_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.abb.2011.11.003","volume":"523","author":"G Jones","year":"2012","unstructured":"G. Jones, D.E. Prosser, M. Kaufmann, 25-hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D. Arch. Biochem. Biophys. 523(1), 9\u201318 (2012). doi: 10.1016\/j.abb.2011.11.003","journal-title":"Arch. Biochem. Biophys."},{"issue":"1\u20132","key":"931_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.mce.2004.07.012","volume":"226","author":"K Tashiro","year":"2004","unstructured":"K. Tashiro, T. Abe, N. Oue, W. Yasui, M. Ryoji, Characterization of vitamin D-mediated induction of the CYP 24 transcription. Mol. Cell. Endocrinol. 226(1\u20132), 27\u201332 (2004). doi: 10.1016\/j.mce.2004.07.012","journal-title":"Mol. Cell. Endocrinol."},{"issue":"7","key":"931_CR15","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"M.F. Holick, N.C. Binkley, H.A. Bischoff-Ferrari, C.M. Gordon, D.A. Hanley, R.P. Heaney, M.H. Murad, C.M. Weaver, S. Endocrine, Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96(7), 1911\u20131930 (2011). doi: 10.1210\/jc.2011-0385","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"931_CR16","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1210\/jc.2014-1413","volume":"99","author":"JP Bilezikian","year":"2014","unstructured":"J.P. Bilezikian, M.L. Brandi, R. Eastell, S.J. Silverberg, R. Udelsman, C. Marcocci, J.T. Potts Jr, Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J. Clin. Endocrinol. Metab. 99(10), 3561\u20133569 (2014). doi: 10.1210\/jc.2014-1413","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"931_CR17","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1210\/jc.2015-2022","volume":"100","author":"MD Walker","year":"2015","unstructured":"M.D. Walker, E. Cong, J.A. Lee, A. Kepley, C. Zhang, D.J. McMahon, S.J. Silverberg, Vitamin D in primary hyperparathyroidism: effects on clinical, biochemical, and densitometric presentation. J. Clin. Endocrinol. Metab. 100(9), 3443\u20133451 (2015). doi: 10.1210\/jc.2015-2022","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"931_CR18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1365-2265.2003.01696.x","volume":"58","author":"F Cetani","year":"2003","unstructured":"F. Cetani, E. Pardi, S. Borsari, M. Tonacchera, E. Morabito, A. Pinchera, C. Marcocci, G. Dipollina, Two Italian kindreds with familial hypocalciuric hypercalcaemia caused by loss-of-function mutations in the calcium-sensing receptor (CaR) gene: functional characterization of a novel CaR missense mutation. Clin. Endocrinol. 58(2), 199\u2013206 (2003)","journal-title":"Clin. Endocrinol."},{"issue":"6","key":"931_CR19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, D. Roth, A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal Disease study group. Ann. Intern. Med. 130(6), 461\u2013470 (1999)","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"931_CR20","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.bone.2008.08.106","volume":"43","author":"EM Lewiecki","year":"2008","unstructured":"E.M. Lewiecki, C.M. Gordon, S. Baim, M.B. Leonard, N.J. Bishop, M.L. Bianchi, H.J. Kalkwarf, C.B. Langman, H. Plotkin, F. Rauch, B.S. Zemel, N. Binkley, J.P. Bilezikian, D.L. Kendler, D.B. Hans, S. Silverman, International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. Bone. 43(6), 1115\u20131121 (2008). doi: 10.1016\/j.bone.2008.08.106","journal-title":"Bone."},{"issue":"7","key":"931_CR21","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1210\/jc.2008-2006","volume":"94","author":"E Vignali","year":"2009","unstructured":"E. Vignali, G. Viccica, D. Diacinti, F. Cetani, L. Cianferotti, E. Ambrogini, C. Banti, R. Del Fiacco, J.P. Bilezikian, A. Pinchera, C. Marcocci, Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 94(7), 2306\u20132312 (2009). doi: 10.1210\/jc.2008-2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"931_CR22","volume-title":"Primary hyperparathyroidism and the kidney. The parathyroids. Basic and clinical concepts.","author":"M Peacock","year":"2015","unstructured":"M. Peacock, Primary hyperparathyroidism and the kidney. The parathyroids. Basic and clinical concepts. (Elsevier Inc., London, 2015)"},{"issue":"8","key":"931_CR23","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1210\/jc.2011-0569","volume":"96","author":"L Rejnmark","year":"2011","unstructured":"L. Rejnmark, P. Vestergaard, L. Mosekilde, Nephrolithiasis and renal calcifications in primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 96(8), 2377\u20132385 (2011). doi: 10.1210\/jc.2011-0569","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"931_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.urology.2014.01.016","volume":"84","author":"MA Elkoushy","year":"2014","unstructured":"M.A. Elkoushy, A.X. Yu, R. Tabah, R.J. Payne, A. Dragomir, S. Andonian, Determinants of urolithiasis before and after parathyroidectomy in patients with primary hyperparathyroidism. Urology. 84(1), 22\u201326 (2014). doi: 10.1016\/j.urology.2014.01.016","journal-title":"Urology."},{"issue":"6","key":"931_CR25","first-page":"359","volume":"18","author":"A D\u2019Angelo","year":"1992","unstructured":"A. D\u2019Angelo, M.G. Lodetti, S. Giannini, R. Castrignano, M. Al Awady, L. Malvasi, A. Fabris, G. Maschio, Hyperparathyroidism: cause or consequence of recurrent calcium nephrolithiasis? Miner. Electrolyte. Metab. 18(6), 359\u2013364 (1992)","journal-title":"Miner. Electrolyte. Metab."},{"issue":"3","key":"931_CR26","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00240-007-0096-2","volume":"35","author":"CV Odvina","year":"2007","unstructured":"C.V. Odvina, K. Sakhaee, H.J. Heller, R.D. Peterson, J.R. Poindexter, P.K. Padalino, C.Y. Pak, Biochemical characterization of primary hyperparathyroidism with and without kidney stones. Urol. Res. 35(3), 123\u2013128 (2007). doi: 10.1007\/s00240-007-0096-2","journal-title":"Urol. Res."},{"issue":"3","key":"931_CR27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0002-9343(90)90346-F","volume":"89","author":"SJ Silverberg","year":"1990","unstructured":"S.J. Silverberg, E. Shane, T.P. Jacobs, E.S. Siris, F. Gartenberg, D. Seldin, T.L. Clemens, J.P. Bilezikian, Nephrolithiasis and bone involvement in primary hyperparathyroidism. Am. J. Med. 89(3), 327\u2013334 (1990)","journal-title":"Am. J. Med."},{"issue":"6","key":"931_CR28","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/cen.12210","volume":"79","author":"F Tassone","year":"2013","unstructured":"F. Tassone, L. Gianotti, C. Baffoni, G. Visconti, M. Pellegrino, S. Cassibba, C.G. Croce, G. Magro, F. Cesario, R. Attanasio, G. Borretta, Vitamin D status in primary hyperparathyroidism: a Southern European perspective. Clin. Endocrinol. 79(6), 784\u2013790 (2013). doi: 10.1111\/cen.12210","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"931_CR29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2265.2004.01946.x","volume":"60","author":"V Carnevale","year":"2004","unstructured":"V. Carnevale, G. Manfredi, E. Romagnoli, S. De Geronimo, F. Paglia, J. Pepe, A. Scillitani, E. D\u2019Erasmo, S. Minisola, Vitamin D status in female patients with primary hyperparathyroidism: does it play a role in skeletal damage? Clin. Endocrinol. 60(1), 81\u201386 (2004)","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"931_CR30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ejim.2011.07.008","volume":"23","author":"W Saliba","year":"2012","unstructured":"W. Saliba, I. Lavi, H.S. Rennert, G. Rennert, Vitamin D status in primary hyperparathyroidism. Eur. J. Intern. Med. 23(1), 88\u201392 (2012). doi: 10.1016\/j.ejim.2011.07.008","journal-title":"Eur. J. Intern. Med."},{"issue":"2","key":"931_CR31","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1530\/eje.1.02197","volume":"155","author":"B Moosgaard","year":"2006","unstructured":"B. Moosgaard, P. Vestergaard, L. Heickendorff, F. Melsen, P. Christiansen, L. Mosekilde, Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study. Eur. J. Endocrinol. 155(2), 237\u2013244 (2006). doi: 10.1530\/eje.1.02197","journal-title":"Eur. J. Endocrinol."},{"issue":"9","key":"931_CR32","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/BF03346273","volume":"27","author":"H Raef","year":"2004","unstructured":"H. Raef, S. Ingemansson, S. Sobhi, A. Sultan, M. Ahmed, M. Chaudhry, The effect of vitamin D status on the severity of bone disease and on the other features of primary hyperparathyroidism (pHPT) in a vitamin D deficient region. J. Endocrinol. Invest. 27(9), 807\u2013812 (2004). doi: 10.1007\/BF03346273","journal-title":"J. Endocrinol. Invest."},{"issue":"3","key":"931_CR33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00268-005-0239-y","volume":"30","author":"N Ozbey","year":"2006","unstructured":"N. Ozbey, Y. Erbil, E. Ademoglu, S. Ozarmagan, U. Barbaros, A. Bozbora, Correlations between vitamin D status and biochemical\/clinical and pathological parameters in primary hyperparathyroidism. World. J. Surg. 30(3), 321\u2013326 (2006). doi: 10.1007\/s00268-005-0239-y","journal-title":"World. J. Surg."},{"issue":"5","key":"931_CR34","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/j.1365-2265.2007.03109.x","volume":"68","author":"B Moosgaard","year":"2008","unstructured":"B. Moosgaard, S.E. Christensen, P. Vestergaard, L. Heickendorff, P. Christiansen, L. Mosekilde, Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism. Clin. Endocrinol. 68(5), 707\u2013715 (2008). doi: 10.1111\/j.1365-2265.2007.03109.x","journal-title":"Clin. Endocrinol."},{"issue":"12","key":"931_CR35","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s00268-002-6433-2","volume":"26","author":"E Nordenstrom","year":"2002","unstructured":"E. Nordenstrom, J. Westerdahl, B. Lindergard, P. Lindblom, A. Bergenfelz, Multifactorial risk profile for bone fractures in primary hyperparathyroidism. World. J. Surg. 26(12), 1463\u20131467 (2002). doi: 10.1007\/s00268-002-6433-2","journal-title":"World. J. Surg."},{"issue":"1","key":"931_CR36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1507\/endocrj.K07-102","volume":"55","author":"Y Inoue","year":"2008","unstructured":"Y. Inoue, H. Kaji, I. Hisa, T. Tobimatsu, J. Naito, M.F. Iu, T. Sugimoto, K. Chihara, Vitamin D status affects osteopenia in postmenopausal patients with primary hyperparathyroidism. Endocr. J. 55(1), 57\u201365 (2008)","journal-title":"Endocr. J."},{"issue":"Suppl 2","key":"931_CR37","first-page":"N75","volume":"17","author":"DS Rao","year":"2002","unstructured":"D.S. Rao, G. Agarwal, G.B. Talpos, E.R. Phillips, F. Bandeira, S.K. Mishra, A. Mithal, Role of vitamin D and calcium nutrition in disease expression and parathyroid tumor growth in primary hyperparathyroidism: a global perspective. J. Bone. Miner. Res. 17(Suppl 2), N75\u201380 (2002)","journal-title":"J. Bone. Miner. Res."},{"issue":"7","key":"931_CR38","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1210\/jc.2011-0238","volume":"96","author":"P Farahnak","year":"2011","unstructured":"P. Farahnak, G. Larfars, M. Sten-&&&&&&&Linder, I.L. Nilsson, Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers. J. Clin. Endocrinol. Metab. 96(7), 2112\u20132118 (2011). doi: 10.1210\/jc.2011-0238","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"931_CR39","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1210\/jc.2004-1772","volume":"90","author":"A Grey","year":"2005","unstructured":"A. Grey, J. Lucas, A. Horne, G. Gamble, J.S. Davidson, I.R. Reid, Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. J. Clin. Endocrinol. Metab. 90(4), 2122\u20132126 (2005). doi: 10.1210\/jc.2004-1772","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"931_CR40","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s12020-009-9211-1","volume":"36","author":"ML Isidro","year":"2009","unstructured":"M.L. Isidro, B. Ruano, Biochemical effects of calcifediol supplementation in mild, asymptomatic, hyperparathyroidism with concomitant vitamin D deficiency. Endocrine. 36(2), 305\u2013310 (2009). doi: 10.1007\/s12020-009-9211-1","journal-title":"Endocrine."},{"issue":"1","key":"931_CR41","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1530\/EJE-08-0901","volume":"161","author":"JR Tucci","year":"2009","unstructured":"J.R. Tucci, Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D. Eur. J. Endocrinol. 161(1), 189\u2013193 (2009). doi: 10.1530\/EJE-08-0901","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"931_CR42","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1210\/jc.2013-3978","volume":"99","author":"L Rolighed","year":"2014","unstructured":"L. Rolighed, L. Rejnmark, T. Sikjaer, L. Heickendorff, P. Vestergaard, L. Mosekilde, P. Christiansen, Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial. J. Clin. Endocrinol. Metab. 99(3), 1072\u20131080 (2014). doi: 10.1210\/jc.2013-3978","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-0931-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-016-0931-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-0931-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-0931-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:57:17Z","timestamp":1559440637000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-016-0931-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,31]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["931"],"URL":"https:\/\/doi.org\/10.1007\/s12020-016-0931-8","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,31]]}}}